FDA Application
-
NDC Search Results on Active Ingredient: fluticasone propionate
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
FLUTICASONE PROPIONATE | 0135-0576-12 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
FLUTICASONE PROPIONATE | 0135-0582-03 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0696-00 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 0135-0576-04 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 59310-520-08 | Teva Respiratory, LLC | NDA208799 | HUMAN PRESCRIPTION DRUG | NDA |
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 68258-3031-1 | Dispensing Solutions, Inc. | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE; AZELASTINE HYDROCHLORIDE | 0037-0245-23 | Meda Pharmaceuticals Inc. | NDA202236 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0696-04 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0716-20 | GlaxoSmithKline LLC | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0695-00 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 50090-0731-0 | A-S Medication Solutions | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0715-22 | GlaxoSmithKline LLC | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 0135-0576-18 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
FLUTICASONE PROPIONATE | 0173-0718-20 | GlaxoSmithKline LLC | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 71143-375-01 | OptiNose US, Inc. | NDA209022 | HUMAN PRESCRIPTION DRUG | NDA |
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 33261-874-01 | Aidarex Pharmaceuticals LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 21695-361-60 | Rebel Distributors Corp. | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 0135-0576-02 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0173-0697-04 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 59310-505-08 | Teva Respiratory, LLC | NDA208798 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 21695-197-01 | Rebel Distributors Corp. | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 50090-0934-0 | A-S Medication Solutions | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 50090-1245-0 | A-S Medication Solutions | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 0135-0576-03 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
FLUTICASONE PROPIONATE | 66993-791-97 | Prasco Laboratories | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
FLUTICASONE PROPIONATE | 50090-7076-0 | A-S Medication Solutions | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 66993-585-97 | Prasco Laboratories | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
FLUTICASONE PROPIONATE | 66993-790-97 | Prasco Laboratories | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 66993-584-97 | Prasco Laboratories | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
FLUTICASONE PROPIONATE | 66993-080-96 | Prasco Laboratories | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
301-330 | 331-360 | 361-390 | 391-419 |
-